Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl cyclopent-2-ene-1-carbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

144019-33-0

Post Buying Request

144019-33-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

144019-33-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 144019-33-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,0,1 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 144019-33:
(8*1)+(7*4)+(6*4)+(5*0)+(4*1)+(3*9)+(2*3)+(1*3)=100
100 % 10 = 0
So 144019-33-0 is a valid CAS Registry Number.

144019-33-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl cyclopent-2-ene-1-carbamate

1.2 Other means of identification

Product number -
Other names N-Boc-2-cyclopentenylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:144019-33-0 SDS

144019-33-0Relevant academic research and scientific papers

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

-

, (2020/07/31)

The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein.

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

-

, (2020/07/31)

The invention relates to novel heteroaryl compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cardiovascular diseases, and methods treating sepsis or septic shock, using the novel heterocyclic compounds disclosed herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 144019-33-0